ImmuPharma plc (LON:IMM – Get Free Report)’s stock price traded up 23.5% on Friday . The company traded as high as GBX 4.70 ($0.06) and last traded at GBX 4.32 ($0.05). 86,096,039 shares traded hands during mid-day trading, an increase of 204% from the average session volume of 28,338,043 shares. The stock had previously closed at GBX 3.50 ($0.04).
ImmuPharma Trading Up 23.5 %
The stock has a fifty day moving average price of GBX 1.40 and a 200 day moving average price of GBX 1.65. The firm has a market cap of £18.00 million, a price-to-earnings ratio of -432.20 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Read More
- Five stocks we like better than ImmuPharma
- Best Stocks Under $5.00
- 3 EV Stocks Offering Unique Alternatives to Tesla
- What is a Special Dividend?
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- How to buy stock: A step-by-step guide for beginners
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
